The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above information ...
Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products and ...
Who Can File a Zantac (Ranitidine) Lawsuit to Recover Damages? As of April 2020, the Food and Drug Administration requested that all manufacturers of prescription and over-the-counter Zantac and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results